VEGFA and fetal growth restriction: Our results are similar to those of the European EVERREST Prospective Study, which investigated the attitudes toward a phase I clinical trial of in utero Vascular Endothelial Growth Factor (VEGF) to treat severe early-onset fetal growth restriction (FGR) among women who had previously enrolled in the EVERREST Study [26].